Authors' reply to the Letter by Infantino et al. commenting on Bonroy et al.: Anti-DFS70 in different settings, CCLM 2018;56:1090-9
Clin Chem Lab Med
.
2019 Mar 26;57(4):e47-e48.
doi: 10.1515/cclm-2018-0754.
Authors
Carolien Bonroy
1
,
Mario Berth
2
,
Sofie Schouwers
3
,
Lieve Van Hoovels
4
Affiliations
1
Department of Laboratory Medicine, Ghent University Hospital, De Pintelaan 185 (2P8), Ghent B-9000, Belgium.
2
Immunology Department, Algemeen Medisch Laboratorium (AML), Antwerp, Belgium.
3
Department of Laboratory Medicine, GZA Hospital, Antwerp, Belgium.
4
Department of Laboratory Medicine, OLV Hospital, Aalst, Belgium.
PMID:
30173202
DOI:
10.1515/cclm-2018-0754
No abstract available
Keywords:
DFS70/LEDGF; antinuclear antibodies; systemic rheumatic autoimmune diseases.
Publication types
Letter
Comment
MeSH terms
Antibodies, Antinuclear*
Fluorescent Antibody Technique, Indirect
Substances
Antibodies, Antinuclear